Treatment of stage I seminoma: is it time to change your practice?

Authors:
Feldman DR; Bosl GJ.

Journal:
J Hematol Oncol

Publication Year: 2008

DOI:
10.1186/1756-8722-1-22

PMCID:
PMC2588624

PMID:
18992162

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Hematol Oncol

Abbreviation: J Hematol Oncol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Hematology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
FFAR2 expressing myeloid-derived suppressor cells drive cancer immunoevasion.
Zhao Z; Qin J; Qian Y and 11 more (2024) - Transparency Score: 3/6
Aging microenvironment and antitumor immunity for geriatric oncology: the landscape and future impl…
Zhao B; Wu B; Feng N and 4 more (2023) - Transparency Score: 3/6
Amino acid metabolism in immune cells: essential regulators of the effector functions, and promisin…
Yang L; Chu Z; Liu M and 7 more (2023) - Transparency Score: 3/6
A phase 1/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and …
Short NJ; Muftuoglu M; Ong F and 24 more (2023) - Transparency Score: 4/6
A pH-dependent anti-CD47 antibody that selectively targets solid tumors and improves therapeutic ef…
Li Y; Liu J; Chen W and 13 more (2023) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
0/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Funding Disclosure
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025